Translating the desmoplastic microenvironment of medullary thyroid cancer into surgical practice
- PMID: 39349720
- DOI: 10.1007/s12020-024-04060-3
Translating the desmoplastic microenvironment of medullary thyroid cancer into surgical practice
Abstract
Purpose: The tumor microenvironment often induces a scarring process known as tumor fibrosis or desmoplasia, which plays an important role in the initiation, progression, and clinical outcome of many types of cancer. This report aimed to highlight recent progress made in the field of de-escalation surgery for sporadic medullary thyroid cancer (MTC), building a bridge from basic science to current and emerging medical practice.
Methods: This narrative review entails a holistic description and interpretation of the English-language literature on MTC desmoplasia.
Results: Absence of primary tumor desmoplasia on intraoperative frozen section and definitive histopathology goes hand in hand with absence of node metastases in up to one-third of patients with sporadic MTC. Patients with desmoplasia-negative MTC require no more than hemithyroidectomy for cure.
Conclusion: Thyroid desmoplasia is a powerful predictive tissue biomarker for the intraoperative management of patients with sporadic MTC, outpacing conventional tumor classification systems that depend on definitive histopathology.
Keywords: Node Metastases; Desmoplasia; Medullary Thyroid Carcinoma.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Compliance with ethical standards. Conflict of interest: The authors declare no competing interests. Ethics approval: All data, being in the public domain, were exempt from institutional review board oversight as per applicable national and local regulations.
Similar articles
-
Abandoning node dissection for desmoplasia-negative encapsulated unifocal sporadic medullary thyroid cancer.Surgery. 2022 Feb;171(2):360-367. doi: 10.1016/j.surg.2021.07.035. Epub 2021 Oct 1. Surgery. 2022. PMID: 34602296
-
Tumor desmoplasia outperforms preoperative serum calcitonin as surgical biomarker in sporadic medullary thyroid cancer.Head Neck. 2024 Nov;46(11):2843-2852. doi: 10.1002/hed.27827. Epub 2024 Jun 8. Head Neck. 2024. PMID: 38850101
-
Surgical Treatment of Medullary Thyroid Cancer.Recent Results Cancer Res. 2025;223:247-266. doi: 10.1007/978-3-031-80396-3_10. Recent Results Cancer Res. 2025. PMID: 40102261 Review.
-
Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy.Surgery. 2023 Dec;174(6):1356-1362. doi: 10.1016/j.surg.2023.09.003. Epub 2023 Oct 10. Surgery. 2023. PMID: 37821265
-
Latest Progress in Risk-Adapted Surgery for Medullary Thyroid Cancer.Cancers (Basel). 2024 Feb 24;16(5):917. doi: 10.3390/cancers16050917. Cancers (Basel). 2024. PMID: 38473279 Free PMC article. Review.
Cited by
-
The value of 18F-FDG PET/CT and 18F-DOPA PET/CT in determining the initial surgical strategy of patients with medullary thyroid cancer : Preoperative PET/CT imaging for medullary thyroid cancer.Cancer Imaging. 2025 Mar 26;25(1):41. doi: 10.1186/s40644-025-00862-4. Cancer Imaging. 2025. PMID: 40140941 Free PMC article.
References
-
- O. Koperek, C. Scheuba, C. Puri, P. Birner, C. Haslinger, W. Rettig, B. Niederle, K. Kaserer, P. Garin Chesa, Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma. Int. J. Oncol. 31, 59–67 (2007) - PubMed
-
- O. Koperek, O. Bergner, B. Pichlhöfer, F. Oberndorfer, J.A. Hainfellner, K. Kaserer, R. Horvat, A.L. Harris, B. Niederle, P. Birner, Expression of hypoxia-associated proteins in sporadic medullary thyroid cancer is associated with desmoplastic stroma reaction and lymph node metastasis and may indicate somatic mutations in the VHL gene. J. Pathol. 225, 63–72 (2011) - DOI - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical